A key impediment for assessing the influence of Fc-effector function on the induction of gut inflammation in syngeneic tumor models has been the lack of measurable inflammation and colitis using surrogate anti-mouse CTLA4 antibodies. This evidence concerns the gene CTLA4 and neoplasm.